RT Generic
T1 Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.
A1 Perez-Belmonte, Luis M
A1 Miramontes-Gonzalez, Jose P
A1 Osuna-Sanchez, Julio
A1 Lara, Jose P
A1 Gómez-Huelgas, Ricardo
K1 Benzhydryl Compounds
K1 Diabetes Mellitus, Type 2
K1 Glucosides
K1 Heart Failure
AB We greatly appreciate the comments from Ismayilovet al. 1 regarding our recent publication on the clinicalbenefits of empagliflozin in very old patients in the hospi-tal setting.
PB American Geriatrics Society
YR 2022
FD 2022-01-29
LK http://hdl.handle.net/10668/19985
UL http://hdl.handle.net/10668/19985
LA en
NO Pérez-Belmonte LM, Miramontes-González JP, Osuna-Sánchez J, Lara JP, Gómez-Huelgas R. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. J Am Geriatr Soc. 2022;70:1585-1589
DS RISalud
RD Apr 7, 2025